An increasing number of drugs have been implicated in the etiology of eosinophilic pneumonia characterized by the development of pulmonary infiltrates, and peripheral blood eosinophilia. Naproxen is a commonlyused nonsteroidal anti-inflammatory drug which may be added to the growing list of pharmacologic agents associated with infiltrative pulmonary lesions. A case of eosinophilic pneumonia induced by Naproxen is described. The results of TBLB, a lymphocytestimulation test, and a challenge test supported this diagnosis.
revealed that the patient had been taking Naproxen, 300 mg daily, during the previous three wks for osteoarthritis. The physical examination revealed the following The physical examination revealed the following: lymphocytes, 2%monocytes, and 55% eosinophils.
The hemoglobin level was 10.7 g/dl with a hematocrit value of 36.0%. The erythrocyte sedimentation rate was 124 mm/h. The C-reactive protein was 23.3 mg/dl, and IgE level was 440 U/ml. The following laboratory values were normal or negative: urine analysis, stools for ova and parasites, serum electrolytes, total protein, albumin, and mycobacterial and fungal cultures of sputum. The ECGrevealed a normal sinus rhythm. Chest X-ray film on admission ( Fig. 1) showed diffuse reticulolinear shadows in the right lung field. Chest CT scan 7 days after admission (Fig. 2) showed diffuse interstitial shadows with partial infiltrative change in the right lung field. Bronchoalveolar lavage (BAL) was performed using a total volume of 150ml of sterile saline solu- A transbronchial lung biopsy (TBLB) obtained from right S4 (Fig. 3) showed alveolar septal thicking and predominant eosinophilic infiltration in the alveolus and septa.
The result of a lymphocyte stimulation test (LST) of Naproxen was not significant (344 cpm, 167%).
Regarding the clinical course, due to the suspicion of drug-induced pneumonitis, the Naproxen therapy was discontinued and 2 days after admission she was administered prednisolone therapy, 30 mg/day.
Within 10 days, the fever and cough were resolved and the white blood cell count was diminished to 1,500/fit 1 with 5% eosinophils. Three wks later the chest X-ray showed marked resolution of all infiltrates (Fig. 4) . Though the result of a lymphocyte stimulation test of Naproxen was negative, the patient was challenged with Naproxen, The link between drugs and pulmonary damage has becomemore evident and the list of drugs implicated in lung injury has grown during the last decade. In a 1972 review of the subject, Rosenow We believe the present case represents a pulmonary hypersensitivity reaction to Naproxen manifested by fever, dry cough, exertional dyspnea, peripheral lung infiltrates, and blood eosinophilia.
Uponcessation of Naproxen therapy and the use of steroid therapy, there was clinical improvement of the illness. Rechallenge with Naproxen produced similar symptoms, a similar chest roentgenogram, and eosinophilia. The extrapulmonary complications of Naproxen are well known, but to our knowledge only six cases of Naproxen induced-lung disease have been reported (6) (7) (8) (9) .
Lymphocyte predominent alveolitis induced by other drugs (10, ll) is well known. In the present patient, the finding of BALFand TBLBrevealed marked eosinophil predominency.
It is important to be aware of the possibility of such a complication occurring in patients treated with Naproxen.
